Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 41.30
+0.11 (0.27%)
Sep 29, 2025, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 13.05 billion as of September 29, 2025. Its market cap has increased by 5.58% in one year.
Market Cap
13.05B
Enterprise Value
14.32B
Revenue
1.84B
Ranking
n/a
PE Ratio
26.16
Stock Price
41.30
Market Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 13.05B, a decrease of -21.00%. That is a compound annual growth rate of -5.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 13.05B | 14.39% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
| May 20, 2021 | 16.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 460.98B |
| WuXi AppTec | 299.67B |
| Shenzhen Mindray Bio-Medical Electronics | 289.04B |
| Sichuan Biokin Pharmaceutical | 149.53B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.41B |
| Shanghai United Imaging Healthcare | 118.35B |
| Aier Eye Hospital Group | 115.45B |
| Yunnan Baiyao Group Co.,Ltd | 101.90B |